The Board has determined that new and relevant evidence supports readjudicating the claim for an initial compensable rating for multiple myeloma. The Veteran's TDIU claim is also remanded due to its inextricable link with the initial rating claim.
The deciding factor: New VAMC West Palm oncology records were submitted after the December 2022 decision, and they are relevant to determining whether the Veteran's multiple myeloma was symptomatic at any point during the appeal period.
- Claimed conditions
- Multiple Myeloma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- March 28, 2024
- Citation
- A24015047
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24015047.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Veteran's multiple myeloma is rated as noncompensable, and the Board has determined that the disability picture does not adequately contemplate his symptoms of fatigue. The VA examiner noted marked interference with employment due to fatigue. Therefore, the claim for an increased rating is remanded for consideration of extraschedular considerations.
- Granted
The Veteran's death was caused by multiple myeloma, which is presumed to be related to his exposure to herbicide agents in Thailand during the Vietnam War. The Board granted service connection for the cause of the Veteran's death based on this presumption.
- Remanded (sent back)
The Veteran's claim for TDIU prior to December 2023 is remanded due to the presence of a 100% disability rating for multiple myeloma starting from December 21, 2023. The Board finds that the Veteran has not met the schedular criteria for a schedular TDIU rating and refers the case for extraschedular consideration.
- Remanded (sent back)
The Board has remanded the claims for service connection for fatigue, dizziness, and chronic kidney disease secondary to the Veteran's service-connected multiple myeloma due to a pre-decisional duty-to-assist error.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.